Biomedicines, Volume 12, Issue 10
2024 October - 254 articles
Cover Story: Busulfan is an FDA-approved alkylating drug used in the chemotherapy of advanced acute myeloid leukemia. The precise mechanisms by which Busulfan kills spermatogonia stem cells (SSCs) are not yet completely understood. Using a murine model, we compared Busulfan-induced apoptosis between testis and ovary tissues. In the testis, the mRNA levels of TNF-α and TAF7 are downregulated, and testosterone levels are suppressed. We executed in situ hybridization and single-nuclei RNA sequencing, finding that less TAF7 mRNA is present in SSCs after chemotherapy. Thus, our data indicate a possible function of TAF7 in the regulation of SSCs and spermatogenesis following downregulation by Busulfan. These findings underlie the potential impact of Busulfan on cancer chemotherapy prognosis. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.